Breastfeeding and Aspirin: Safety, Risks, and Practical Precautions

Short answer: Low-dose aspirin (81 mg daily) has been studied in breastfeeding and showed no detectable aspirin in milk, with very low levels of its metabolite; however, routine use of standard or high-dose aspirin is generally discouraged because of potential infant risks (platelet effects and theoretical Reye’s syndrome), so alternatives like acetaminophen or ibuprofen are usually preferred. ^[1] Regular-strength aspirin product labels commonly advise caution or avoidance during lactation due to limited data and potential risks, emphasizing that benefits must be weighed against risks. ^[2] Many combination aspirin products and certain formulations explicitly advise against breastfeeding during use because of these uncertainties and risks. ^{[3] [4]}

---

What we know about aspirin in breast milk

• Low-dose exposure data: In a small study of mothers taking 81 mg daily, aspirin itself was undetectable in milk; salicylic acid (the active metabolite) was present at low concentrations over 24 hours, suggesting minimal infant exposure at this dose. ^[1] This supports that low-dose aspirin may result in low transfer into milk, though individual variability exists. ^[1]
• Limited evidence overall: Many authoritative drug monographs state there are no adequate studies to fully determine infant risk during breastfeeding and recommend weighing benefits and risks. ^[2] Similar caution is echoed across multiple aspirin-containing product labels. ^{[5] [6]}

---

Potential risks to the infant

• Platelet effects: Labels warn that aspirin in breast milk may potentially affect the infant’s platelet function, which could increase bleeding tendency. ^[4]
• Reye’s syndrome (theoretical risk): Direct aspirin use in infants and children has been associated with Reye’s syndrome; while it is unknown if maternal aspirin during lactation raises this risk, several products advise that breastfeeding is not recommended during certain aspirin therapies because of this concern. ^[3] This is a precautionary stance due to the seriousness of Reye’s syndrome. ^[3]

---

Practical precautions if aspirin is clinically needed

• Prefer the lowest effective dose: If aspirin is medically indicated (for example, cardiovascular prevention), low-dose regimens are generally considered to have lower milk transfer. ^[1] Use the minimum dose needed and avoid higher doses when possible. ^{[1] [2]}
• Avoid high-dose or prolonged use: Standard-dose (e.g., 325 mg or more) and frequent dosing raise exposure and are often discouraged in breastfeeding by product information. ^[7] Discuss any non–low-dose use with your clinician. ^[7]
• Time feeds strategically: Although aspirin levels were undetectable in milk at low dose, salicylic acid appeared in milk over time; feeding just before a dose and allowing several hours afterward may further reduce exposure, especially with low-dose therapy. ^[1]
• Watch your baby: Monitor for unusual bruising, bleeding (e.g., nosebleeds), poor feeding, vomiting, or lethargy; seek medical advice if any occur, as these could signal platelet effects or other issues. ^[4]
• Avoid certain combinations: Some combination products (e.g., aspirin with codeine, barbiturates, or omeprazole in fixed-dose combos) specifically advise against breastfeeding due to multiple ingredient risks, including aspirin. ^{[4] [3]} Check labels and consult before using combination products. ^{[4] [3]}
• Consider safer pain/fever alternatives: Acetaminophen and ibuprofen are generally preferred during breastfeeding when appropriate, as they have more reassuring lactation data compared with aspirin. ^[2]

---

When aspirin may be appropriate

• Cardiovascular indications: For a clear medical need (e.g., low-dose aspirin for secondary prevention of heart disease or stroke), clinicians often weigh the benefits of maternal therapy against the small but not fully defined infant risks. ^[2] This risk–benefit discussion is important and should be individualized. ^[2]
• Stroke prevention combinations: Extended-release dipyridamole with aspirin carries similar breastfeeding cautions; labels state insufficient information on infant effects and advise balancing maternal need with potential infant risk. ^{[5] [6]} If such therapy is required, close pediatric and maternal follow-up is advisable. ^{[5] [6]}

---

Clear guidance from product information

• General caution: Several official drug descriptions emphasize that breastfeeding decisions should balance maternal benefit and potential infant risk due to limited data. ^[2] This is why many labels avoid firm “safe” statements and recommend medical guidance. ^[2]
• Explicit discouragement in some products: Certain formulations advise that breastfeeding is not recommended during treatment because it is unknown if lactational exposure increases Reye’s risk, and due to potential platelet effects. ^{[3] [4]} Heed product-specific warnings. ^{[3] [4]}

---

Bottom line

• Low-dose aspirin (81 mg daily) shows minimal milk transfer in limited data and may be compatible when clearly indicated, with precautions and monitoring. ^[1]
• Standard or high-dose aspirin use during breastfeeding is generally discouraged due to potential infant risks and limited evidence. ^{[7] [2]}
• When aspirin is required, use the lowest effective dose, avoid combinations with additional risk, time feeds, and monitor your baby prefer alternatives like acetaminophen or ibuprofen for routine pain/fever when appropriate. ^{[2] [4] [1] [7]}